← FDA DRUG APPROVALS

FDA ANDA · ANDA077241

BACLOFEN

Sponsor: LANNETT CO INC

APPLICATION
ANDA077241
TYPE
ANDA
ORIGINAL APPROVAL
2005-12-20
LATEST ACTION
2021-09-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

BACLOFENPrescription
BACLOFEN 10MG · TABLET · ORAL
BACLOFENPrescription
BACLOFEN 5MG · TABLET · ORAL
BACLOFENPrescription
BACLOFEN 20MG · TABLET · ORAL

Approval history

2021-09-22Manufacturing (CMC) · Supplement 21 · unknownAP
2020-10-29Labeling · Supplement 20 · standardAP
2015-04-16Labeling · Supplement 1AP
2015-04-16Labeling · Supplement 11 · standardAP
2008-08-13Labeling · Supplement 5AP
2005-12-20OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →